Chinese Journal of Clinical Hepatology最新文献

筛选
英文 中文
IDDF2023-ABS-0171 Prospective evaluation of a fast-track treatment pathway for patients with chronic hepatitis B under primary care IDDF2023-ABS-0171初级保健下慢性乙型肝炎患者快速通道治疗途径的前瞻性评估
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.144
C. Lai, V. Wong, Vicki Wing-Ki Hui, Y. Tse, T. Yip, H. Chan, G. Wong
{"title":"IDDF2023-ABS-0171 Prospective evaluation of a fast-track treatment pathway for patients with chronic hepatitis B under primary care","authors":"C. Lai, V. Wong, Vicki Wing-Ki Hui, Y. Tse, T. Yip, H. Chan, G. Wong","doi":"10.1136/gutjnl-2023-iddf.144","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.144","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76230295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0021 Outcomes of the conventional side-viewing duodenoscope for ERCP in Billroth II gastrectomy patients 传统侧视十二指肠镜检查Billroth II型胃切除术患者ERCP的结果
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.124
Tao Li
{"title":"IDDF2023-ABS-0021 Outcomes of the conventional side-viewing duodenoscope for ERCP in Billroth II gastrectomy patients","authors":"Tao Li","doi":"10.1136/gutjnl-2023-iddf.124","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.124","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82635681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0074 Pretreatment prediction of T cell-inflamed gene expression profile in hepatocellular carcinoma: a contrast-enhanced ultrasound radiomics-based machine learning model 肝细胞癌中T细胞炎症基因表达谱的预处理预测:基于对比增强超声放射学的机器学习模型
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.130
Yijie Wang, Han Xiao, Ruiming Liang, S. Peng, W. Wang
{"title":"IDDF2023-ABS-0074 Pretreatment prediction of T cell-inflamed gene expression profile in hepatocellular carcinoma: a contrast-enhanced ultrasound radiomics-based machine learning model","authors":"Yijie Wang, Han Xiao, Ruiming Liang, S. Peng, W. Wang","doi":"10.1136/gutjnl-2023-iddf.130","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.130","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90143011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0132 Evaluation of the targeted pathological indicators related to the combining targeted therapy and immunotherapy in hepatocellular carcinoma based on multi-parameter magnetic resonance imaging 基于多参数磁共振成像的肝细胞癌靶向与免疫联合治疗的相关病理指标评价
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.138
Chenyu Song, S. Feng
{"title":"IDDF2023-ABS-0132 Evaluation of the targeted pathological indicators related to the combining targeted therapy and immunotherapy in hepatocellular carcinoma based on multi-parameter magnetic resonance imaging","authors":"Chenyu Song, S. Feng","doi":"10.1136/gutjnl-2023-iddf.138","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.138","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90549729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0125 Global influence of arginine methylation on phase separation for carcinogenesis 精氨酸甲基化对癌相分离的全球影响
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.137
Susu Luo
{"title":"IDDF2023-ABS-0125 Global influence of arginine methylation on phase separation for carcinogenesis","authors":"Susu Luo","doi":"10.1136/gutjnl-2023-iddf.137","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.137","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76721295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0299 Effectiveness of relink initiatives to re-engage diagnosed-but-untreated HCV-positive patients with direct-acting antiviral treatment iddf2023 - ab -0299重新链接计划的有效性,使诊断但未经治疗的hcv阳性患者重新接受直接作用抗病毒治疗
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.156
M. Buti, A. Branch, M. Mendizabal, J. Drenth, V. Ledinghen, Elena Vargas Accarino, B. Kreter, Stacey Scherbakovsky
{"title":"IDDF2023-ABS-0299 Effectiveness of relink initiatives to re-engage diagnosed-but-untreated HCV-positive patients with direct-acting antiviral treatment","authors":"M. Buti, A. Branch, M. Mendizabal, J. Drenth, V. Ledinghen, Elena Vargas Accarino, B. Kreter, Stacey Scherbakovsky","doi":"10.1136/gutjnl-2023-iddf.156","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.156","url":null,"abstract":"BackgroundHepatitis C virus (HCV) infection is a major cause of chronic liver disease that can progress to cirrhosis and hepatocellular carcinoma. The WHO has identified HCV infection as a public health threat and set a global target for HCV elimination by 2030. Simple pangenotypic direct-acting antiviral regimens allow most patients to be cured with minimal pretreatment and on-treatment monitoring. To achieve the WHO goal, patients including previously diagnosed HCV-positive patients who have been lost to follow-up, need to be linked to care. Studies report that up to 60% of patients who test positive for HCV antibodies are lost to follow-up and not treated. This loss has been further exacerbated by the COVID-19 pandemic, and many patients put off receiving care. Here, we explore the effectiveness of care re-engagement programs for patients with HCV.MethodsWe assessed ReLink programs (sponsored by Gilead Sciences, Inc.), designed to identify and re-engage HCV-positive patients with medical care and start/restart HCV treatment. We evaluated these programs by analyzing the number of patients, steps in the care cascade where patients were lost to follow-up, and the efficacy of the engagement program (determined by the number relinked and treated).ResultsSix programs assessed 44,964 patient records, identifying 11,163 patients lost to follow-up and eligible for contact. The main reason for the loss of follow-up was the inability to contact patients. Overall, 3726 patients were relinked with care, and 701 were treated. Several key points were identified for improving patient engagement with care, including the use of electronic databases to identify patients lost to follow-up, securing reliable contact information for patients, and partnership with medical societies.ConclusionsActive case finding, patient navigation, and care coordination in these programs led to increased engagement and treatment rates. Engaging HCV-positive patients with care is urgent, as many may already have developed more advanced liver disease. Adopting and adapting effective strategies from these programs may be a feasible way to improve patient outcomes and increase treatment numbers, thus contributing to meeting the WHO goal of HCV elimination.","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90715271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0022 ERCP in the patients with situs inversus totalis: a case series IDDF2023-ABS-0022完全性倒位患者的ERCP:一个病例系列
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.125
Wenying Yang
{"title":"IDDF2023-ABS-0022 ERCP in the patients with situs inversus totalis: a case series","authors":"Wenying Yang","doi":"10.1136/gutjnl-2023-iddf.125","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.125","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"197 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74499541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0140 The liver frailty index is an independent predictor of mortality in patients with advanced hepatocellular carcinoma undergoing systemic therapy: a multicentre prospective observational study 肝衰弱指数是接受全身治疗的晚期肝细胞癌患者死亡率的独立预测因子:一项多中心前瞻性观察性研究
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.139
Karen Waller, D. Prince, M. Levy, S. Strasser, G. McCaughan, Margaret Teng, D. Huang
{"title":"IDDF2023-ABS-0140 The liver frailty index is an independent predictor of mortality in patients with advanced hepatocellular carcinoma undergoing systemic therapy: a multicentre prospective observational study","authors":"Karen Waller, D. Prince, M. Levy, S. Strasser, G. McCaughan, Margaret Teng, D. Huang","doi":"10.1136/gutjnl-2023-iddf.139","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.139","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72837369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0262 Incidence, mortality and temporal trends of liver cancer in chinese: a population-based analysis 中国人肝癌的发病率、死亡率和时间趋势:基于人群的分析
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.151
Junjie Huang, S. Chan, Martin C. S. Wong
{"title":"IDDF2023-ABS-0262 Incidence, mortality and temporal trends of liver cancer in chinese: a population-based analysis","authors":"Junjie Huang, S. Chan, Martin C. S. Wong","doi":"10.1136/gutjnl-2023-iddf.151","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.151","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90506183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2023-ABS-0112 Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy iddf2023 - ab -0112非缺血性扩张型心肌病患者肝纤维化评分的预后意义
Chinese Journal of Clinical Hepatology Pub Date : 2023-06-01 DOI: 10.1136/gutjnl-2023-iddf.136
Yu-peng Liu, Jingjing Song, Wen-yao Wang, Yifang Tang
{"title":"IDDF2023-ABS-0112 Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy","authors":"Yu-peng Liu, Jingjing Song, Wen-yao Wang, Yifang Tang","doi":"10.1136/gutjnl-2023-iddf.136","DOIUrl":"https://doi.org/10.1136/gutjnl-2023-iddf.136","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"138 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77408638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信